MN Cannabis Hub - April 23, 2026

Minnesota's adult-use cannabis market, nearly three years in, is grappling with high prices, low supply, and inconsistent quality, frustrating consumers like David in Rochester who can't afford his medicine at $50-70 for 3.5 grams. The Office of Cannabis Management is working through cultivation applications, while regulatory uncertainty and local ordinances create further challenges for businesses and consumers. House File 3104 aims to address municipal conflicts, and consumers are advised to check QR codes for Certificates of Analysis for safety. Key Highlights: • Minnesota's cannabis market faces high prices and inconsistent quality due to a severe shortage of licensed cultivators unable to meet demand. • Medical patients are particularly affected by supply shortages of specific, medically-focused cannabis strains, impacting their healthcare access. • Regulatory uncertainty from local zoning disputes and moratoriums creates instability for cannabis businesses and consumers across the state. • Consumers are urged to check product QR codes for Certificates of Analysis (COAs) to verify cannabinoid profiles and safety following inaccurate THC labeling concerns. Topics: Minnesota cannabis, adult-use market, high prices, low supply, cannabis quality, Office of Cannabis Management, regulatory uncertainty, local ordinances, House File 3104, product labeling, Certificate of Analysis, medical cannabis patients --- TRANSCRIPT ### MN Cannabis Hub Podcast Script Episode Title: The Price of Green: Tackling High Costs and Low Supply in Minnesota Date: April 23, 2026 Host: Alex Peterson (Intro Music: Upbeat, chill, lo-fi hip-hop beat. Fades in and then fades to background.) Alex Peterson: Welcome to the MN Cannabis Hub, your weekly source for Minnesota cannabis news, education, and industry updates. I’m your host, Alex Peterson. Today is April 23rd, 2026, and we’re now nearly three years into Minnesota’s adult-use cannabis market. The initial excitement has settled, and now we’re dealing with the very real growing pains of a new industry. This week, we’re diving deep into the issues you’ve been talking about. We’ve been listening to our community, and the message is loud and clear: you’re frustrated with high prices, inconsistent quality, and persistent shortages. We’re going to break down why this is happening, what’s being done about it, and what you can do to be a smarter consumer. Let’s get into it. (Sound effect: Gentle transition swoosh) Alex: Our first segment is one we’re calling “The Big Squeeze,” and it tackles the number one complaint we hear from all of you. It’s summed up perfectly by this message we got from a medical patient named David in Rochester. He writes, “$50-70 for 3.5 grams is outrageous. At this price, I can't afford my medicine.” David, you are not alone. This sentiment has an intensity rating of 9 out of 10 in our community feedback, and for good reason. So, why are prices so stubbornly high in Minnesota? It’s a classic case of supply and demand. Right now, there are simply not enough licensed cultivators in the state to meet the massive demand from both medical patients and adult-use consumers. The Office of Cannabis Management has been working through a mountain of applications, but getting a large-scale cultivation facility fully operational—from construction to first harvest—is a multi-year, multi-million dollar process. This limited supply creates a bottleneck. And when supply is low and demand is high, prices naturally go up. This directly connects to our second major pain point: product quality. We heard from a listener in Minneapolis who said, “I paid top-shelf prices for what is essentially LARF (leafy, lower-quality material). This is unacceptable.” And they’re right, it is. When producers know that anything they grow will sell out instantly due to shortages, there’s less competitive pressure to ensure every single bud is top-tier. The incentive to rush products to market can sometimes override meticulous quality control. These two issues—high prices and low quality—are symptoms of the same core problem: a market that is still finding its footing. The good news is that as more cultivators come online over the next year or two, we expect to see increased competition drive both prices down and quality up. But for now, we’re in the thick of it. For a more detailed breakdown of the economic factors at play, including state taxes and testing costs, check out our full report at mncannabishub.com/marketanalysis. (Sound effect: Gentle transition music for a few seconds) Alex: The supply bottleneck isn’t just about the amount of cannabis available; it’s also about variety. This leads us to another major frustration: supply shortages of specific products. A patient from Duluth told us, “I went to three different dispensaries and none of them had the strain I need for my neuropathy. The supply shortage is a real problem for patients.” This is a critical issue. For recreational users, not finding a specific strain might be an inconvenience. For a medical patient who relies on the specific terpene and cannabinoid profile of a strain like, say, Harlequin or ACDC for relief, it’s a genuine healthcare crisis. This comes back to the limited number of growers. With a smaller overall genetic library in the state and pressure to grow high-yielding, popular THC-dominant strains, many of the niche, medically-focused cultivars get left behind. So what’s the solution? We’re seeing a rise in craft cannabis licenses, which could help fill these gaps with more diverse and specialized products. We’ll be keeping a close eye on that. Now, let’s pivot from the product on the shelf to the rules governing the shelf itself. (Sound effect: Gentle transition swoosh) Alex: Regulatory uncertainty is casting a long shadow over the industry. We heard from a consumer in St. Cloud who’s worried, saying, “How can I be sure that the dispensary I rely on will even be open next month? The constant fighting between the growers and the local government is creating a lot of uncertainty.” This is a huge deal. What we’re seeing is a patchwork of local ordinances. While cannabis is legal statewide, individual municipalities can still create zoning laws and moratoriums that make it incredibly difficult for businesses to operate. We’re tracking ongoing zoning disputes in several suburban counties that have put dispensary and cultivation applications in limbo. This uncertainty doesn't just affect business owners; it trickles down to you, the consumer, creating those very real fears about access and stability. The state legislature is aware of these municipal conflicts, and there’s a bill, House File 3104, being discussed that aims to create more uniform statewide standards to prevent these local-level roadblocks. We’ll have a link to track that bill’s progress on our website. And finally, let’s talk about a pain point that is less about frustration and more about safety: product recalls and labeling. A recent recall of a batch of flower from a southern Minnesota producer due to inaccurate THC labeling sparked a lot of concern. One user wrote to us, “It's scary to think that the product I'm using might have a higher THC content than what's on the label. This is a safety issue.” This is absolutely a safety issue, and it’s a top priority for the Office of Cannabis Management. Inaccurate labeling can happen for a few reasons: inconsistent lab testing methods, producers "lab shopping" for the highest numbers, or just the natural variance within a single harvest. So, what can you do as a consumer? My number one piece of advice is this: look for the QR code. Every legal cannabis product in Minnesota must have a QR code on its packaging that links to a Certificate of Analysis, or COA. This is the official lab report for that specific batch. It will show you the detailed cannabinoid and terpene profile, as well as testing for pesticides, heavy metals, an...